| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Mometasone furoate 1 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Mometasone furoate 1 mg/g cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Fluticasone propionate 500 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar+salicylic acid ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| koltjära 10 %, preparat för pensling |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar 7.5% paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Zinc+coal tar paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar ointment BPC |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| stark koltjärelösning 40 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar 10 mg/mL cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| koltjära 40 %, emulsion för bad |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| stark koltjärelösning 5 % + talltjära 5 % |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar 10 mg/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| koltjärelösning 10 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Allantoin 20 mg/g and coal tar extract 50 mg/g cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely allantoin 20 milligram/1 gram and coal tar extract 50 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Coal tar 20% solution BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| antralin, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| ditranol 0,25 % + salicylsyra 1,6 %, gel för användning i hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely coal tar 10 milligram/1 gram and dithranol 1.1 milligram/1 gram and salicylic acid 16 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Ichthammol 10% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Zinc+ichthammol cream BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Salicylic acid 2% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Zinc+salicylic acid paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| zink + salicylsyra (halv styrka), pasta |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely calcipotriol 50 microgram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Calcipotriol 50 microgram/mL cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| kalcipotriol 50 mikrogram/ml, lösning för användning i hårbottnen |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| takalcitol (som takalcitolmonohydrat) 4 mikrogram/gram, kutan salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| tazaroten 0,05 %, vattenhaltig gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| tazaroten 0,1 %, vattenhaltig gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.1% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.2% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.5% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 1.5% ointment BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.2% paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.5% paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Dithranol 20 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely dithranol 30 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 0.1% paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Anthralin 1% paste BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Dithranol 2.5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Dithranol 5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Dithranol 10 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Dithranol 1 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| antralin 0,2 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| antralin 0,4 %, kräm |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzalkonium 2.5 mg/g and polyethylene 219 mg/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| aluminiumoxid 52,2 %, pasta |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Aluminium oxide 381 mg/g cutaneous paste |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/g and potassium hydroxyquinoline sulfate 5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| bensoylperoxid 5 % + kaliumhydroxikinolinsulfat 0,5 %, gellotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Sulfur+salicylic acid cream BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Sulfur+salicylic acid ointment BPC |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely tetracycline hydrochloride 2.2 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Tretinoin 250 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Tretinoin 100 microgram/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Tretinoin 500 microgram/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely tretinoin 250 microgram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Tretinoin 250 microgram/g cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| klindamycin 1 %, roll-onlotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| klindamycin 1 %, alkohollösning för lokalt bruk |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 20 milligram/1 gram conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely nicotinamide 40 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely adapalene 1 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 40 milligram/1 gram conventional release cutaneous cream (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous lotion (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzoyl peroxide 50 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Benzoyl peroxide 100 mg/g cutaneous lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 100 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| bensoylperoxid 2,5 %, vattenhaltig gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| bensoylperoxid 5 %, vattenhaltig gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| bensoylperoxid 10 %, vattenhaltig gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| bensoylperoxid 10 %, sköljvätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely benzoyl peroxide 50 milligram/1 gram conventional release cutaneous gel (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Salicylic acid collodion BP 12% |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Lactic acid 250 mg/g and salicylic acid 250 mg/g cutaneous ointment |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| salicylsyra 3 % + borsyra i renat talk 5 %, pulver |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| salicylsyra 5 % + zinkoxid 20 %, puder |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| salicylsyra 60 % i vitt mjukt paraffin 40 %, salva |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| salicylsyra 17 %, vätska |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 260 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Salicylic acid 110 mg/g cutaneous gel |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| salicylsyra 16,7 % + mjölksyra 16,7 %, preparat för pensling |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely salicylic acid 500 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| brominkomplex |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| formaldehyd 36 %, lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| formaldehyd 10 %, lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| formaldehyd 15 %, lotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| formaldehydlotion |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Podophyllin compound 15% paint BP |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely Podophyllum resin 200 milligram/1 gram and salicylic acid 250 milligram/1 gram conventional release cutaneous ointment (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Podophyllotoxin 5 mg/mL cutaneous solution |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Podophyllotoxin 1.5 mg/g cutaneous cream |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| dimetyleterpropanaerosol |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Toughened silver nitrate BP 95% stick |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| aminobensoesyralösning |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| kamouflerande preparat |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| Product containing precisely povidone iodine 40 milligram/1 milliliter conventional release cutaneous shampoo (clinical drug) |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|
| koltjäreextrakt 2 %, schampo |
Has manufactured dose form |
False |
kutan och/eller transdermal läkemedelsform |
Inferred relationship |
Some |
|